Chongqing Zhifei Biological Products Co., Ltd. (300122.SZ)
CNY 27.93
(-0.78%)
CNY 27.93
(-0.78%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 52.67 Billion | 38.26 Billion | 30.65 Billion | 15.19 Billion | 10.58 Billion | 5.22 Billion |
| Cost of Revenue | 38.67 Billion | 25.39 Billion | 15.62 Billion | 9.26 Billion | 6.13 Billion | 2.36 Billion |
| Gross Profit | 14 Billion | 12.86 Billion | 15.03 Billion | 5.92 Billion | 4.45 Billion | 2.86 Billion |
| Operating Expenses | 4.54 Billion | 3.56 Billion | 2.71 Billion | 1.75 Billion | 1.47 Billion | 1.05 Billion |
| Selling, General and Administrative Expenses | 2 Billion | 2.32 Billion | 1.92 Billion | 1.26 Billion | 1.15 Billion | 803.11 Million |
| Research and Development Expenses | 968.47 Million | 854.16 Million | 552.62 Million | 299.65 Million | 169.55 Million | 142.94 Million |
| Other Expenses | 1.89 Billion | 382.2 Million | 239.83 Million | 187.66 Million | 154.61 Million | -20.42 Million |
| Cost and Expenses | 43.54 Billion | 28.96 Billion | 18.34 Billion | 11.02 Billion | 7.61 Billion | 3.42 Billion |
| Operating Income | 9.37 Billion | 8.75 Billion | 11.99 Billion | 3.89 Billion | 2.81 Billion | 1.71 Billion |
| Interest Expense | 117.43 Million | 53.29 Million | 56.14 Million | 127.14 Million | 76.11 Million | 27.03 Million |
| Income Tax Expense | 1.27 Billion | 1.17 Billion | 1.72 Billion | 552.74 Million | 398.93 Million | 240.85 Million |
| Earnings before Tax | 9.34 Billion | 8.71 Billion | 11.93 Billion | 3.85 Billion | 2.76 Billion | 1.69 Billion |
| Net Income | 8.06 Billion | 7.53 Billion | 10.2 Billion | 3.3 Billion | 2.36 Billion | 1.45 Billion |
| Earnings Per Share Basic | 3.36 | 3.14 | 4.25 | 1.38 | 0.99 | 0.60 |
| Earnings Per Share Diluted | 3.36 | 3.14 | 4.25 | 1.38 | 0.99 | 0.59 |
| Weighted Average Shares Outstanding | 2.4 Billion | 2.39 Billion | 2.39 Billion | 2.39 Billion | 2.39 Billion | 2.39 Billion |
| Weighted Average Shares Outstanding (Diluted) | 2.4 Billion | 2.39 Billion | 2.39 Billion | 2.39 Billion | 2.39 Billion | 2.46 Billion |
| Gross Margin | 0.27 | 0.34 | 0.49 | 0.39 | 0.42 | 0.55 |
| EBIT Margin | 0.19 | 0.25 | 0.41 | 0.28 | 0.28 | 0.36 |
| Profit Margin | 0.15 | 0.20 | 0.33 | 0.22 | 0.22 | 0.28 |
| EBITDA | 9.79 Billion | 9.08 Billion | 12.39 Billion | 4.1 Billion | 2.93 Billion | 1.8 Billion |
| Earnings Before Tax Margin | 0.18 | 0.23 | 0.39 | 0.26 | 0.27 | 0.33 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 4.52 Billion | 6.86 Billion | 11.34 Billion | 52.67 Billion | 13.58 Billion | 14.82 Billion |
| Cost of Revenue | 3.18 Billion | 4.99 Billion | 8.42 Billion | 38.74 Billion | 10.52 Billion | 10.94 Billion |
| Gross Profit | 1.33 Billion | 1.87 Billion | 2.91 Billion | 13.93 Billion | 3.06 Billion | 3.87 Billion |
| Operating Expenses | 1.17 Billion | 980.03 Million | 1.18 Billion | 4.73 Billion | 1.33 Billion | 893.3 Million |
| Selling, General and Administrative Expenses | 1.36 Billion | 555.94 Million | 946.87 Million | - | 816.74 Million | 889.51 Million |
| Research and Development Expenses | 234.19 Million | 227.26 Million | 234.08 Million | - | 319.92 Million | 211.66 Million |
| Other Expenses | -423.82 Million | -980.03 Million | -1.02 Million | -311.99 Million | -196.85 Million | -11.66 Million |
| Cost and Expenses | 4.36 Billion | 5.93 Billion | 9.6 Billion | 43.47 Billion | 11.85 Billion | 11.84 Billion |
| Operating Income | -94.41 Million | 852.16 Million | 1.73 Billion | 9.2 Billion | 1.72 Billion | 2.66 Billion |
| Interest Expense | 34.48 Million | 24.74 Million | 24.48 Million | 80.99 Million | 23.38 Million | 17.95 Million |
| Income Tax Expense | -11.05 Million | 62.36 Million | 276.02 Million | 1.27 Billion | 183.67 Million | 386.34 Million |
| Earnings before Tax | -94.74 Million | 838.93 Million | 1.73 Billion | 9.34 Billion | 1.72 Billion | 2.65 Billion |
| Net Income | -83.69 Million | 776.57 Million | 1.45 Billion | 8.06 Billion | 1.53 Billion | 2.27 Billion |
| Earnings Per Share Basic | -0.04 | 0.32 | 0.61 | - | 0.64 | 0.95 |
| Earnings Per Share Diluted | -0.04 | 0.32 | 0.61 | - | 0.64 | 0.95 |
| Weighted Average Shares Outstanding | 2.39 Billion | 2.39 Billion | 2.4 Billion | 2.4 Billion | 2.4 Billion | 2.4 Billion |
| Weighted Average Shares Outstanding (Diluted) | 2.39 Billion | 2.39 Billion | 2.4 Billion | 2.4 Billion | 2.4 Billion | 2.4 Billion |
| Gross Margin | 0.30 | 0.27 | 0.26 | 0.26 | 0.23 | 0.26 |
| EBIT Margin | -0.01 | 0.14 | 0.19 | - | 0.13 | 0.20 |
| Profit Margin | -0.02 | 0.11 | 0.13 | 0.15 | 0.11 | 0.15 |
| EBITDA | -60.26 Million | 952.57 Million | 2.1 Billion | - | 1.81 Billion | 2.97 Billion |
| Earnings Before Tax Margin | -0.02 | 0.12 | 0.15 | 0.17 | 0.13 | 0.18 |
PBR-A
1890
JPPHY
1053
601898
ARTO